Related Experiment Video
Updated: Jun 4, 2026
05:39
Spontaneous Murine Model of Anaplastic Thyroid Cancer
Published on: February 3, 2023
Recurrent thyroid cancer: a molecular-based therapeutic breakthrough.
1Institut Jules Bordet, Medical Oncolgy Clinic, Université Libre de Bruxelles, Brussels, Belgium.
Current Opinion in Oncology
|February 19, 2011
Summary
New molecular-targeted therapies show promise for treating advanced thyroid cancer. These targeted drugs, including kinase inhibitors, offer improved outcomes for patients with recurrent disease unresponsive to traditional treatments.
Area of Science:
- Oncology
- Molecular Biology
- Pharmacology
Background:
- Thyroid cancer incidence is rising, presenting significant challenges in managing recurrent cases unresponsive to conventional treatments like surgery or radio-iodine ablation.
- Chemotherapy offers limited efficacy for advanced thyroid cancer, highlighting the need for novel therapeutic strategies.
Purpose of the Study:
- To review recent advancements in understanding thyroid cancer biology and the development of targeted therapies.
- To evaluate the efficacy of novel agents, particularly molecular-targeted therapies, in managing recurrent thyroid cancer.
Main Methods:
- Review of recent scientific literature focusing on thyroid cancer carcinogenesis, molecular signaling pathways, and drug development.
- Analysis of clinical trial data for agents targeting molecular pathways, including angiogenesis inhibitors and kinase inhibitors.
Main Results:
- Significant progress in comprehending thyroid cancer development and identifying new drug targets over the past decade.
- Promising results observed with various targeted agents, showing disease stabilization and response rates in different thyroid cancer subtypes.
- Recent evidence indicates an improvement in progression-free survival with these novel therapies.
Conclusions:
- Molecular-targeted therapies, especially multitargeted kinase inhibitors, have demonstrated significant clinical interest.
- These targeted agents have advanced to phase III randomized clinical trials, confirming their potential in clinical practice for thyroid cancer management.
Related Concept Videos
02:57Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
02:57Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
02:56Treatment Resistent Cancers
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
02:56Treatment Resistant Cancers
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
01:05Cancer-Critical Genes II: Tumor Suppressor Genes
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
01:05Cancer-Critical Genes II: Tumor Suppressor Genes
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...